Aggelies

In addition, it is expected that almotriptan malate (AXERT®) is generally Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) Milligram. Almotriptan is a headache medicine that narrows blood vessels around the brain. Almotriptan also reduces substances in the body that can. Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan Malate, Tablet, coated, mg/1, Oral, Patriot Pharmaceuticals,

Author: Mikataxe Mamuro
Country: Chad
Language: English (Spanish)
Genre: Art
Published (Last): 10 June 2014
Pages: 150
PDF File Size: 15.46 Mb
ePub File Size: 20.78 Mb
ISBN: 313-8-91488-914-7
Downloads: 43239
Price: Free* [*Free Regsitration Required]
Uploader: Kagakus

Cabazitaxel The metabolism of Cabazitaxel can be decreased when combined with Almotriptan.

Ethadione The risk or severity of adverse effects can be increased when Almotriptan is combined with Ethadione. Diacerein The metabolism of Almotriptan can be decreased when combined with Diacerein. Carisbamate The risk or severity of adverse effects can be increased when Almotriptan is combined with Carisbamate.

Some patients might rarely have an increase in common side effects of almotriptan, such as dizziness, nausea or drowsiness. Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Almotriptan. Almotriptan should be used cautiously in patients with hepatic disease. Framycetin Framycetin may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Signs and symptoms of serotonin syndrome include autonomic instability e. Dabigatran etexilate Almotriptan may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level. The recommended starting dose of almotriptan is 6. Fosphenytoin The metabolism of Fosphenytoin can be decreased when combined with Almotriptan.

Eslicarbazepine acetate The risk or severity of adverse effects can be increased when Almotriptan is combined with Eslicarbazepine acetate. The manufacturers of serotonin agonists contraindicate the administration of their drugs to patients receiving non-selective MAO inhibitors or within 2 weeks of discontinuation of a MAO inhibitor.

Concomitant use of two serotonin-augmenting drugs has been associated with serotonin syndrome, so concurrent use of the serotonin-receptor agonists with sibutramine is not recommended. Cloxazolam The risk or severity of adverse effects can be increased when Almotriptan is combined with Cloxazolam.

  EL LADO OCULTO DE LAS COSAS LEADBEATER PDF

Almotriptan

Apronalide The risk or severity of adverse effects can be increased when Almotriptan is combined with Apronalide. Minor Lumacaftor; ivacaftor may reduce the efficacy of almotriptan by decreasing its systemic exposure. Concomitant almoteiptan of almotriptan and potent CYP3A4 inhibitors is expected to increase almotriptan exposure.

Ibutilide Ibutilide may decrease the excretion rate of Almotriptan which could result in a higher serum level. Etanercept The metabolism of Almotriptan can be increased when combined with Etanercept. Felodipine The metabolism of Felodipine can be decreased when combined with Almotriptan.

Beclomethasone dipropionate The metabolism of Almotriptan can be increased zlmotriptan combined with Beclomethasone dipropionate. Gilteritinib The therapeutic efficacy of Almotriptan can be decreased when used in combination with Gilteritinib. Hydracarbazine The metabolism of Almotriptan can be decreased when combined with Hydracarbazine.

Almotriptan is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine.

Clomipramine Malatee metabolism of Clomipramine can be decreased when combined with Almotriptan.

Ifosfamide The metabolism of Almotriptan can be increased when combined with Ifosfamide. Glasdegib The metabolism of Glasdegib can be decreased when combined with Almotriptan. Biperiden The metabolism of Almotriptan can be decreased when combined with Mzlate. Chlorphentermine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Chlorphentermine.

Bupropion The metabolism of Almotriptan can be decreased when combined with Bupropion. Idazoxan The risk or severity of hypertension can be increased when Almotriptan is combined with Idazoxan.

Carbromal The risk or severity of adverse effects can be increased when Almotriptan is combined with Carbromal. Cefroxadine Cefroxadine may decrease the excretion rate of Almotriptan which could result in amlate higher serum level.

Ephedrine The risk or severity of hypertension can be increased when Almotriptan is combined with Ephedrine. Emtricitabine Mlaate may decrease the excretion rate of Emtricitabine which could result in a higher serum level. Bendroflumethiazide Bendroflumethiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.

  KOCHOWSKI PSALMODIA POLSKA PDF

Clozapine The metabolism of Almotriptan can be decreased when combined with Clozapine.

Almotriptan – Side Effects, Dosage, Interactions – Drugs – Everyday Health

Almotriptan is contraindicated in patients with cerebrovascular disease, including stroke or history of transient ischemic attack. Brincidofovir Brincidofovir may decrease the excretion rate of Almotriptan which could result in a higher serum level. For the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more when untreated.

Cannabidivarin The risk or severity of adverse effects can be increased when Almotriptan is combined with Cannabidivarin. Diethyl ether The risk or severity of adverse effects can be increased when Almotriptan is combined with Diethyl ether. Epirizole Epirizole may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Fenquizone Fenquizone may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy. Furazolidone The metabolism of Almotriptan can be decreased when combined with Furazolidone. Epinephrine The metabolism of Almotriptan can be decreased when combined with Epinephrine. Frovatriptan The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Frovatriptan.

Alaproclate The risk or severity of adverse effects can be increased when Almotriptan is combined with Alaproclate. The monoamine oxidase MAO type A enzyme metabolizes serotonin. Fenyramidol The risk or severity of adverse effects can be increased when Almotriptan is combined with Fenyramidol. Desflurane The risk or severity of adverse effects can be increased when Almotriptan is combined with Desflurane.